Overview

S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Assess the efficacy and safety of S1 combined with cisplatin in treatment of recurrence/metastasis of ESCC
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Treatments:
Cisplatin